TABLE 2.

Investigator assessments of C/BPO local tolerability at Weeks 2 and 8

	INVESTIGATOR ASSESSMENTS (n=76) WEEK 2		INVESTIGATOR ASSESSMENTS (n=76) WEEK 8
	NO. (%) WITH NO SIGN/SYMPTOM PRESENT	MEAN (SD) SCORE ON 4-POINT SCALE*	NO. (%) WITH NO SIGN/SYMPTOM PRESENT	MEAN (SD) SCORE ON 4-POINT SCALE*
Redness	47 (62.7)	0.41 (0.57)	62 (83.8)	0.19 (0.46)
Dryness	54 (72.0)	0.31 (0.52)	73 (98.6)	0.03 (0.23)
Peeling	54 (72.0)	0.32 (0.55)	71 (95.9)	0.04 (0.20)
Irritant/allergic contact dermatitis	73 (97.3)	0.03 (0.16)	74 (100.0)	0.00 (0.00)

^*0=none, 1=slight, 2=moderate, and 3=intense